Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.

Niu, Jun-Ying

Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. [electronic resource] - Annals of hematology Oct 2018 - 1841-1849 p. digital

Publication Type: Journal Article

1432-0584

10.1007/s00277-018-3382-x doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Area Under Curve
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Etoposide--administration & dosage
Female
Fibrinogen--analysis
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse--blood
Male
Middle Aged
Prednisone--administration & dosage
Prognosis
Proportional Hazards Models
ROC Curve
Retrospective Studies
Risk Assessment
Risk Factors
Rituximab--administration & dosage
Severity of Illness Index
Vincristine--administration & dosage